• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

呼气一氧化氮水平低与囊性纤维化患者的肺功能受损有关。

Low levels of exhaled nitric oxide are associated with impaired lung function in cystic fibrosis.

机构信息

Department of Pediatrics, University of Gothenburg, Queen Silvia Children's Hospital, Gothenburg, Sweden.

出版信息

Pediatr Pulmonol. 2010 Mar;45(3):241-8. doi: 10.1002/ppul.21137.

DOI:10.1002/ppul.21137
PMID:20146368
Abstract

Fraction of exhaled nitric oxide (FENO) is often reduced in cystic fibrosis (CF). FENO at different expiratory flows can provide an indication of the site of nitric oxide production. The aim of this study was to examine whether NO parameters are related to overall (FEV(1)) or peripheral (lung clearance index, LCI, measured by multiple breath SF(6) washout) airway function and systemic inflammation in CF. Secondary aim was to compare alveolar NO and bronchial NO flux calculated by two different mathematical models, a linear and a nonlinear method. Thirty-five healthy and 45 CF children were recruited. FENO at 50 ml/sec (FENO(50)) and bronchial NO flux were lower in CF than controls, 9.5 (2.7-38.8) (median (range)) versus 12.4 (5.2-40.1) ppb, P = 0.029, and 391 (97-1772) versus 578 (123-1993) (pl/sec), P = 0.036, respectively. No difference in alveolar NO was shown. The nonlinear method resulted in lower alveolar NO and higher bronchial flux, than the linear method, but the result was closely correlated in both groups. LCI was higher in CF than controls, 8.4 (6.5-12.9) versus 5.9 (5.1-7.8), P < 0.001. FENO(50) was negatively correlated with LCI (r = -0.43; P = 0.003) and positively correlated with FEV(1) (r = 0.42, P = 0.004) in CF. Alveolar NO correlated negatively with inflammatory markers: orosomucoid (r = -0.42, P = 0.005), platelets (r = -0.50, P < 0.001) and white blood cell count (r = -0.48, P = 0.001). In conclusion, FENO(50) and bronchial NO flux are reduced in young CF subjects and low FENO(50) is associated with overall and small airway obstruction. NO parameters derived from the different models were closely related but the values differed slightly.

摘要

呼出气一氧化氮(FENO)分数在囊性纤维化(CF)中经常降低。不同呼气流量的 FENO 可以提供一氧化氮产生部位的指示。本研究的目的是检查 NO 参数是否与 CF 中的整体(FEV1)或外周(通过多次呼吸 SF6 清除测量的肺清除指数,LCI)气道功能和全身炎症相关。次要目的是比较通过两种不同的数学模型(线性和非线性方法)计算的肺泡 NO 和支气管 NO 通量。招募了 35 名健康儿童和 45 名 CF 儿童。CF 儿童的 FENO(50)(FEV1)和支气管 NO 通量低于对照组,分别为 9.5(2.7-38.8)(中位数(范围))和 12.4(5.2-40.1)ppb,P=0.029,和 391(97-1772)和 578(123-1993)(pl/sec),P=0.036。未显示肺泡 NO 存在差异。与线性方法相比,非线性方法导致肺泡 NO 降低和支气管通量升高,但两种方法的结果在两组中均密切相关。LCI 在 CF 中高于对照组,分别为 8.4(6.5-12.9)和 5.9(5.1-7.8),P<0.001。FENO(50)与 LCI 呈负相关(r=-0.43;P=0.003),与 CF 中的 FEV1 呈正相关(r=0.42,P=0.004)。肺泡 NO 与炎症标志物:粘蛋白(r=-0.42,P=0.005)、血小板(r=-0.50,P<0.001)和白细胞计数(r=-0.48,P=0.001)呈负相关。总之,年轻 CF 患者的 FENO(50)和支气管 NO 通量降低,低 FENO(50)与整体和小气道阻塞相关。两种模型衍生的 NO 参数密切相关,但值略有不同。

相似文献

1
Low levels of exhaled nitric oxide are associated with impaired lung function in cystic fibrosis.呼气一氧化氮水平低与囊性纤维化患者的肺功能受损有关。
Pediatr Pulmonol. 2010 Mar;45(3):241-8. doi: 10.1002/ppul.21137.
2
Alveolar, but not bronchial nitric oxide production is elevated in cystic fibrosis.在囊性纤维化中,肺泡而非支气管的一氧化氮生成增加。
Pediatr Pulmonol. 2007 Dec;42(12):1215-21. doi: 10.1002/ppul.20730.
3
Alveolar and bronchial nitric oxide output in healthy children.健康儿童的肺泡和支气管一氧化氮输出量
Pediatr Pulmonol. 2008 Dec;43(12):1242-8. doi: 10.1002/ppul.20953.
4
Multiple breath inert gas washout as a measure of ventilation distribution in children with cystic fibrosis.多次呼吸惰性气体冲洗法作为评估囊性纤维化患儿通气分布的一种方法。
Thorax. 2004 Dec;59(12):1068-73. doi: 10.1136/thx.2004.022590.
5
Extended nitric oxide measurements in exhaled air of cystic fibrosis and healthy adults.对囊性纤维化患者和健康成年人呼出气体中一氧化氮的延长测量。
Lung. 2009 Sep-Oct;187(5):307-13. doi: 10.1007/s00408-009-9160-8. Epub 2009 Aug 8.
6
Measurement of bronchial and alveolar nitric oxide production in normal children and children with asthma.正常儿童和哮喘儿童支气管及肺泡一氧化氮生成量的测定。
Am J Respir Crit Care Med. 2006 Aug 1;174(3):260-7. doi: 10.1164/rccm.200506-962OC. Epub 2006 Apr 20.
7
Upper and lower airway nitric oxide levels in primary ciliary dyskinesia, cystic fibrosis and asthma.原发性纤毛运动障碍、囊性纤维化和哮喘患者的上、下呼吸道一氧化氮水平。
Respir Med. 2013 Mar;107(3):380-6. doi: 10.1016/j.rmed.2012.11.021. Epub 2013 Jan 3.
8
Alveolar concentration and bronchial flux of nitric oxide: two linear modeling methods evaluated in children and adolescents with allergic rhinitis and atopic asthma.肺泡浓度和支气管一氧化氮通量:两种线性建模方法在过敏性鼻炎和特应性哮喘儿童和青少年中的评估。
Pediatr Pulmonol. 2012 Nov;47(11):1070-9. doi: 10.1002/ppul.22550. Epub 2012 Apr 13.
9
Peripheral inflammation in patients with asthmatic symptoms but normal lung function.有哮喘症状但肺功能正常的患者的外周炎症。
J Asthma. 2005 Sep;42(7):605-9. doi: 10.1080/02770900500294678.
10
Oral bacteria--the missing link to ambiguous findings of exhaled nitrogen oxides in cystic fibrosis.口腔细菌——囊性纤维化患者呼出氮氧化物检测结果不明确的关键因素
Respir Med. 2009 Feb;103(2):187-93. doi: 10.1016/j.rmed.2008.09.009. Epub 2008 Nov 9.

引用本文的文献

1
Host-Directed Therapy in Nontuberculous Mycobacterial Pulmonary Disease: Preclinical and Clinical Data Review.宿主导向治疗在非结核分枝杆菌肺部疾病中的应用:临床前和临床数据回顾。
Clin Chest Med. 2023 Dec;44(4):839-845. doi: 10.1016/j.ccm.2023.07.004. Epub 2023 Aug 23.
2
Effect of airway clearance therapies on mucociliary clearance in adults with cystic fibrosis: A randomized controlled trial.气道清除治疗对成人囊性纤维化患者黏液清除功能的影响:一项随机对照试验。
PLoS One. 2022 May 20;17(5):e0268622. doi: 10.1371/journal.pone.0268622. eCollection 2022.
3
State-of-the-art review of lung imaging in cystic fibrosis with recommendations for pulmonologists and radiologists from the "iMAging managEment of cySTic fibROsis" (MAESTRO) consortium.
肺囊性纤维化影像学的最新研究进展:来自“囊性纤维化的影像学管理”(MAESTRO)联合会的肺科医生和放射科医生的建议。
Eur Respir Rev. 2022 Mar 23;31(163). doi: 10.1183/16000617.0173-2021. Print 2022 Mar 31.
4
Current Molecular Therapeutic Agents and Drug Candidates for .当前用于……的分子治疗剂和候选药物
Front Pharmacol. 2021 Aug 30;12:724725. doi: 10.3389/fphar.2021.724725. eCollection 2021.
5
NO donors and NO delivery methods for controlling biofilms in chronic lung infections.慢性肺部感染中无供体且无输送方法来控制生物膜。
Appl Microbiol Biotechnol. 2021 May;105(10):3931-3954. doi: 10.1007/s00253-021-11274-2. Epub 2021 May 3.
6
Local and Systemic Alterations of the L-Arginine/Nitric Oxide Pathway in Sputum, Blood, and Urine of Pediatric Cystic Fibrosis Patients and Effects of Antibiotic Treatment.小儿囊性纤维化患者痰液、血液和尿液中L-精氨酸/一氧化氮途径的局部和全身改变以及抗生素治疗的影响
J Clin Med. 2020 Nov 24;9(12):3802. doi: 10.3390/jcm9123802.
7
Antibacterial activity of high-dose nitric oxide against pulmonary disease.高剂量一氧化氮对肺部疾病的抗菌活性。
Access Microbiol. 2020 Aug 10;2(9):acmi000154. doi: 10.1099/acmi.0.000154. eCollection 2020.
8
Nitric Oxide-Releasing Cyclodextrins.一氧化氮释放环糊精。
J Am Chem Soc. 2018 Oct 31;140(43):14178-14184. doi: 10.1021/jacs.8b07661. Epub 2018 Oct 16.
9
The Consequences of Being in an Infectious Biofilm: Microenvironmental Conditions Governing Antibiotic Tolerance.处于感染性生物膜中的后果:控制抗生素耐药性的微环境条件。
Int J Mol Sci. 2017 Dec 12;18(12):2688. doi: 10.3390/ijms18122688.
10
Application of nitric oxide measurements in clinical conditions beyond asthma.一氧化氮测量在哮喘以外临床病症中的应用。
Eur Clin Respir J. 2015 Aug 17;2:28517. doi: 10.3402/ecrj.v2.28517. eCollection 2015.